Stocks TORO Financial statements
Financial statementsTORO CORP. financial statements
Income statement, balance sheet and cash flow statement for the last 5 fiscal years, taken from the XBRL data TORO CORP. files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
| FY2022 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|
| Revenue | 29.3 | 15.6 | 22.3 | 22.4 | 21.1 |
| General and administrative | 0.89 | 2.09 | 5.36 | 10.2 | 8.6 |
| Operating income | -0.73 | 6.93 | 8.2 | -5.56 | -4.65 |
| Interest expense | 0.51 | 0.9 | 0.96 | 0.23 | 0.07 |
| Interest income | 0 | 0 | 2.05 | 8.35 | 2.81 |
| Other non-operating income | -0.49 | -0.01 | 3.03 | 11.1 | 10.3 |
| Pre-tax income | -1.22 | 6.92 | 11.2 | 5.51 | 5.61 |
| Income tax | 0.21 | 0 | 0.05 | 0 | 0 |
| Income from continuing operations | 6.92 | 11.2 | 5.51 | 5.61 | |
| Net income | -1.43 | 49.9 | 141 | 25.2 | 5.93 |
| EBITDA | 3.1 | 8.34 | 11.6 | -0.66 | 0.28 |
| EPS, basic | -0.15 | 5.28 | 8.69 | 1.09 | 0.08 |
| EPS, diluted | -0.15 | 1.17 | 2.87 | 1.09 | 0.08 |
| Shares, basic (weighted) | 9.46 | 9.46 | 15.4 | 17.4 | 17.9 |
| Shares, diluted (weighted) | 9.46 | 42.7 | 48.7 | 17.4 | 17.9 |
Balance sheet
| FY2022 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|
| Cash and equivalents | 4.96 | 41.8 | 152 | 37.2 | 87.4 |
| Receivables | 4.1 | 10.6 | 1.4 | 0.42 | 0.07 |
| Inventory | 3.14 | 0.89 | 0.17 | 0.19 | 0.2 |
| Other current assets | 0.4 | 0.92 | 1.11 | 0.29 | 0.55 |
| Total current assets | 12.6 | 54.8 | 165 | 55.3 | 96.3 |
| Property, plant and equipment | 108 | 92.5 | 77 | 72.8 | 96.2 |
| Total assets | 124 | 157 | 308 | 326 | 331 |
| Accounts payable | 0.51 | 1.64 | 1.75 | 0.77 | 1.13 |
| Accrued liabilities | 0.48 | 2.27 | 0.46 | 0.98 | 0.85 |
| Deferred revenue | 0.55 | 0 | 0.31 | 0.98 | 0.77 |
| Total current liabilities | 6.95 | 6.52 | 7.86 | 4.7 | 41.9 |
| Total liabilities | 20 | 17 | 131 | 127 | 168 |
| Total debt | 16 | 13.1 | 5.21 | ||
| Paid-in capital | 0 | 57.2 | 58.6 | 59.3 | |
| Retained earnings | -0 | 120 | 140 | 104 | |
| Treasury stock | 0 | -0.22 | 0 | ||
| Shareholders' equity | 104 | 140 | 177 | 199 | 164 |
| Total equity | 104 | 140 | 177 | 199 | 164 |
| Total liabilities and equity | 124 | 157 | 308 | 326 | 331 |
| Shares outstanding | 0 | 19 | 19.1 | 21.5 |
Cash flow statement
| FY2022 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|
| Net income | -1.43 | 49.9 | 141 | 25.2 | 5.93 |
| Depreciation and amortization | 3.83 | 1.41 | 3.36 | 4.9 | 4.93 |
| Stock-based compensation | 0 | 0 | 1.27 | 5.31 | 3.59 |
| Change in receivables | -4.1 | -0.24 | -0.73 | 0.96 | -0.73 |
| Change in inventory | -3.14 | -0.08 | -0 | -0.02 | -0.08 |
| Change in payables | 0.05 | 0.5 | 1.22 | -0.98 | 0.53 |
| Cash from operations | -4.42 | 41.5 | 56.1 | 10.8 | -6.34 |
| Capital expenditures | -111 | -0.3 | -72.2 | -0.12 | -66.8 |
| Cash from investing | -111 | 11.8 | 50.7 | -155 | 67.8 |
| Debt issued | 18 | 0 | 0 | ||
| Stock issued | 0 | 0 | 18.6 | 0 | 0 |
| Share buybacks | 0 | 0 | -1.05 | -3.73 | 0 |
| Cash from financing | 121 | -16.5 | 6.27 | -5.13 | -11.3 |
| Net change in cash | 5.66 | 36.8 | 113 | -118 | 50.2 |
| Free cash flow | -116 | 41.2 | -16.1 | 10.7 | -73.1 |
| Interest paid | 0.35 | 0.69 | 0.77 |
Key metrics
Profitability
| Metric | Value | How it is calculated |
|---|---|---|
| Operating margin | -22.1% | Operating income / revenue. |
| EBITDA margin | 1.4% | EBITDA (operating income + depreciation and amortization) / revenue. |
| Pre-tax margin | 26.6% | Pre-tax income / revenue. |
| Net margin | 28.1% | Net income / revenue. |
| FCF margin | -346.8% | Free cash flow (cash from operations - capital expenditures) / revenue. |
| Operating cash flow margin | -30.1% | Cash from operations / revenue. |
| Effective tax rate | 0.0% | Income tax / pre-tax income, when pre-tax income is positive. |
| Return on equity (ROE) | 3.3% | Net income / average shareholders' equity (opening and closing). Not shown when equity is negative. |
| Return on assets (ROA) | 1.8% | Net income / average total assets. |
| Return on invested capital (ROIC) | -3.9% | Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%. |
| Stock-based pay / revenue | 17.0% | Stock-based compensation (from the cash flow statement) / revenue. |
| Capex / revenue | 316.7% | Capital expenditures / revenue. |
| D&A / revenue | 23.4% | Depreciation and amortization / revenue. |
Growth
| Metric | Value | How it is calculated |
|---|---|---|
| Revenue growth, 1y | -5.9% | Revenue vs the same period a year earlier. Only from a positive base. |
| Revenue CAGR, 3y | 10.5% | Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| EBITDA CAGR, 3y | -67.5% | Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Net income growth, 1y | -76.5% | Net income vs the same period a year earlier. Only from a positive base. |
| Net income CAGR, 3y | -50.8% | Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| EPS growth, 1y | -92.7% | EPS vs the same period a year earlier. Only from a positive base. |
| EPS CAGR, 3y | -59.1% | Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Operating cash flow growth, 1y | -158.8% | Operating cash flow vs the same period a year earlier. Only from a positive base. |
| Free cash flow growth, 1y | -785.8% | Free cash flow vs the same period a year earlier. Only from a positive base. |
| Book value growth, 1y | -17.8% | Book value vs the same period a year earlier. Only from a positive base. |
| Book value CAGR, 3y | 5.2% | Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Total assets growth, 1y | 1.5% | Total assets vs the same period a year earlier. Only from a positive base. |
| Total assets CAGR, 3y | 28.1% | Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Share count change, 1y | 2.8% | Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution. |
| Share count change per year, 3y | -25.2% | Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution. |
Balance sheet health
| Metric | Value | How it is calculated |
|---|---|---|
| Current ratio | 2.30x | Current assets / current liabilities. |
| Quick ratio | 2.09x | (Cash + short-term investments + receivables) / current liabilities. |
| Cash ratio | 2.08x | (Cash + short-term investments) / current liabilities. |
| Liabilities / assets | 50.6% | Total liabilities / total assets. |
| Interest coverage | -68.3x | Operating income / interest expense. |
| Working capital | $54.4M | Current assets - current liabilities. |
| Tangible book value | $163.6M | Shareholders' equity - goodwill - intangible assets. |
Efficiency
| Metric | Value | How it is calculated |
|---|---|---|
| Asset turnover | 0.06x | Revenue / average total assets. |
| Fixed asset turnover | 0.25x | Revenue / average property, plant and equipment. |
| Receivables turnover | 86.7x | Revenue / average receivables. |
| Days sales outstanding | 4 days | 365 x average receivables / revenue. |
| FCF conversion | -1,232.0% | Free cash flow / net income, when net income is positive. |
Per share
| Metric | Value | How it is calculated |
|---|---|---|
| EPS, diluted | $0.08 | Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS. |
| EPS, basic | $0.08 | Net income per basic share, as reported (split-adjusted). |
| Revenue per share | $1.18 | Revenue / diluted weighted shares. |
| FCF per share | -$4.09 | Free cash flow / diluted weighted shares. |
| Operating cash flow per share | -$0.35 | Cash from operations / diluted weighted shares. |
| Book value per share | $7.62 | Shareholders' equity / shares outstanding (diluted weighted shares when not reported). |
| Tangible book per share | $7.62 | Tangible book value / shares outstanding. |
| Cash per share | $4.07 | (Cash + short-term investments) / shares outstanding. |
Valuation
| Metric | Value | How it is calculated |
|---|---|---|
| Market cap | $152.3M | Share price x shares outstanding. |
| Enterprise value | $64.9M | Market cap + total debt - cash - short-term investments. |
| P/E | 25.7x | Market cap / net income. Only when net income is positive. |
| P/S | 7.23x | Market cap / revenue. |
| P/B | 0.93x | Market cap / shareholders' equity. Only when equity is positive. |
| Price / tangible book | 0.93x | Market cap / tangible book value, when positive. |
| EV/Sales | 3.08x | Enterprise value / revenue. |
| EV/EBITDA | 228x | Enterprise value / EBITDA, when both are positive. |
| FCF yield | -48.0% | Free cash flow / market cap. |
| Earnings yield | 3.9% | Net income / market cap (the inverse of P/E). |
| Shareholder yield | 0.0% | (Dividends paid + share buybacks) / market cap. |
What was TORO CORP.'s revenue in fiscal 2025?
TORO CORP. reported revenue of $21.1M for fiscal 2025, 5.9% lower than the year before.
Was TORO CORP. profitable in fiscal 2025?
Yes. Net income was $5.9M, a net margin of 28.1%.
How much free cash flow did TORO CORP. generate in fiscal 2025?
Cash from operations of $6.3M minus capital expenditures of $66.8M left free cash flow of -$73.1M.